FDA Approves Pfizer's Novel HIV/AIDS Treatment Selzentry.
HEALTH AND BEAUTY CLOSE-UP-1 December 2008-FDA Approves Pfizer's Novel HIV/AIDS Treatment Selzentry(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com The U.S. Food and Drug Administration (FDA) has granted Selzentry (maraviroc) full (traditional) approval for use in treatment-experienced adults with CCR5-tropic HIV-1 in combination with other antiretrovirals. In a...

U.S. global HIV prevention policy: still time to get it right.
Over the summer, the United States strongly recommitted itself to fighting AIDS in the developing world. After months of wrangling earlier in the year, President Bush and congressional conservatives found a way to agree with congressional progressives on legislation renewing the President's Emergency Plan for AIDS Relief (PEPFAR). The...

Experts Address State of HIV/AIDS Care in the Region Following Landmark Assessment Showing Widening Gaps in Social Services.
PITTSBURGH, Nov. 25 /PRNewswire/ -- Medical and social service officials convened today at a briefing hosted by the Pittsburgh AIDS Task Force (PATF) to discuss the results, implications and recommendations of the Southwestern PA Regional HIV/AIDS Needs Assessment study. The region's top HIV/AIDS experts in attendance who provided insight...

New HIV/AIDS care, prevention guides target increasing access.
THE WORLD Health Organization has released a package of priority interventions to help low- and middle-income nations move toward universal access to HIV medications and prevention. WHO officials launched a new HIV/AIDS guide on universal access during the International AIDS Conference in Mexico City in August. The...

M*A*C AIDS Fund Bolsters South Africa HIV Care, Prevention with $2.5 Million USD.
Program grants were raised by consumers in 16 countries to benefit women and children-focused programs at UNICEF and NOAH JOHANNESBURG, South Africa, Nov. 24 /PRNewswire/ -- A new grant program from the M*A*C AIDS Fund has gifted $2.5 million to fight HIV and AIDS in South Africa....

The prevalence of hepatitis B co-infection in a South African urban government HIV clinic.
Objective. There are an estimated 350 million hepatitis B carriers worldwide. In South Africa the prevalence of mono-infection with hepatitis B has been estimated to range from 1% in urban areas to approximately 10% in rural areas. The exact prevalence of hepatitis B in the HIV-infected population has not...

AHF: US Should Spend $200M on HIV Tests for 10 Million People as Domestic Testing Falls Short of CDC Goals.
HEALTH AND BEAUTY CLOSE-UP-25 November 2008-AHF: US Should Spend $200M on HIV Tests for 10 Million People as Domestic Testing Falls Short of CDC Goals(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com Two years after the Centers for Disease Control (CDC) first recommended routine HIV testing for everyone between the...

Zazzle and Edun Live Offer Limited Edition World Aids Day T-Shirts.
ENTERTAINMENT CLOSE-UP-26 November 2008-Zazzle and Edun Live Offer Limited Edition World Aids Day T-Shirts(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com Zazzle, an on-demand retail platform offering products produced in 24 hours, and strategic partner Edun Live, the sister ethical tee-shirt brand of Edun that was founded by Ali Hewson...

Video: Magic Johnson Foundation and Abbott Call for Greater Prevention, Testing and Treatment on World AIDS Day.
Earvin 'Magic' Johnson and Cookie Johnson Public Service Announcement (PSA) focuses on HIV/AIDS and African Americans ABBOTT PARK, Ill., Dec. 1 /PRNewswire-FirstCall/ -- Today, on the 20th anniversary of World AIDS Day, the Magic Johnson Foundation and Abbott are calling on the public to educate themselves, their...

GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America.
'World Aids Day' Commemorated by GeoVax with Hope and Promise ATLANTA, Dec. 1 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (BULLETIN BOARD: GOVX) , an Atlanta-based biotechnology company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, announced today that the launch of...